Spots Global Cancer Trial Database for chloroquine
Every month we try and update this database with for chloroquine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma | NCT01438177 | Multiple Myelom... | Velcade Cyclophosphamid... Chloroquine | 18 Years - | NYU Langone Health | |
Chloroquine for Treatment of Glioblastoma Multiforme | NCT00224978 | Glioblastoma Mu... | Chloroquine | 18 Years - 65 Years | National Institute of Neurology and Neurosurgery, Mexico | |
Study of Whole-brain Irradiation With Chloroquine for Brain Metastases | NCT01894633 | Brain Metastasi... | Chloroquine Total brain rad... | 46 Years - 61 Years | Instituto Nacional de Cancerologia de Mexico | |
Study of Whole-brain Irradiation With Chloroquine for Brain Metastases | NCT01894633 | Brain Metastasi... | Chloroquine Total brain rad... | 46 Years - 61 Years | Instituto Nacional de Cancerologia de Mexico | |
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors | NCT02071537 | Malignant Neopl... Solid Tumors | Chloroquine Carboplatin Gemcitabine | 18 Years - | University of Cincinnati | |
Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer | NCT01575782 | Small Cell Lung... | Chloroquine | 18 Years - | Maastricht Radiation Oncology | |
IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy | NCT01727531 | Brain Metastasi... | Chloroquine dip... | 18 Years - | Main Line Health | |
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis | NCT03449758 | Rheumatoid Arth... | SARILUMAB Azathioprine Chloroquine Hydroxychloroqu... Leflunomide Methotrexate Sulfasalazine | 18 Years - | Sanofi | |
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors | NCT02071537 | Malignant Neopl... Solid Tumors | Chloroquine Carboplatin Gemcitabine | 18 Years - | University of Cincinnati | |
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis | NCT03449758 | Rheumatoid Arth... | SARILUMAB Azathioprine Chloroquine Hydroxychloroqu... Leflunomide Methotrexate Sulfasalazine | 18 Years - | Sanofi | |
Adjuvant Effect of Chloroquine on Gemcitabine | NCT01777477 | Pancreatic Canc... | Chloroquine Gemcitabine | 18 Years - | University of Zurich |